共 83 条
- [11] Nussenblatt RB(2014)Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients Rheumatology (Oxford) 53 2223-943
- [12] Rosenbaum JT(2016)Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients N Engl J Med 375 932-1678
- [13] Nussenblatt RB(2018)Adalimumab in patients with active noninfectious uveitis Br J Ophthalmol 102 1672-1011
- [14] Palestine AG(2018)Adalimumab for the treatment of refractory active and inactive non-infectious uveitis Ann Rheum Dis 77 1003-189
- [15] Chan CC(2017)ADJUVITE Study Group. ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis Clin Rheumatol 36 183-1451
- [16] Roberge F(2018)Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study Ophthalmology 125 1444-718
- [17] Evereklioglu C(2019)Successful optimization of adalimumab therapy in refractory uveitis due to Behçet's disease J Ophthalmic Inflamm Infect 9 14-undefined
- [18] Atienza-Mateo B(2020)Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet's disease-related uveitis Inflammopharmacology 28 711-undefined
- [19] Martín-Varillas JL(2021)Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndrome Int Immunopharmacol 93 107430-undefined
- [20] Calvo-Río V(undefined)Comparative study of adalimumab versus conventional therapy in sight-threatening refractory Behçet's uveitis with vasculitis undefined undefined undefined-undefined